In stock
Guaranteed refund or reship if you haven't received your order
Secure and encrypted payment processing
We ship to over 40 countries including the USA, UK, Europe, Australia and Japan

Pharmacological properties

A non-hormonal herbal preparation with a complex effect, which is due to the synergistic effects of the components that make up the drug and have hormone-regulating, antiproliferative, anti-inflammatory, sedative and restorative effects. flavonoids of biologically active substances of the tazalok preparation are similar in structure to endogenous estrogen, but do not show estrogen-like activity, they are able to compete with estrogen receptors (androgens) when there is an excess of estrogens (androgens) or their receptors in target organs, and they change the activity of aromatase enzymes systems, inhibiting the conversion of androgens to estrogens. Thus, the tazalok exhibits selective antiestrogenic activity, leads to rhythmic production and normalization of the ratio of gonadotropic hormones, helps to reduce prolactin levels and increase progesterone levels, eliminates the imbalance between estradiol and progesterone, and normalizes the second phase of the menstrual cycle. It has a pronounced effect on the glandular tissue and stromal elements of the mammary glands, ovaries and uterus, shows antiproliferative and anti-inflammatory properties, and prevents the development of dysplastic processes in these tissues. with polycystic ovarian disease, it softens the capsule of the cyst, reduces its stress due to resorptive action, enhances the function of the undamaged part of the ovary. promotes active resorption of cyst contents, resorption of painless dense nodes in the mammary glands, reduces the reaction of the mammary glands to the phases of the menstrual cycle. exhibits antispasmodic properties, has a soothing and sedative effect. biologically active molecules of the drug tazalok have the ability to induce and enhance apoptosis, block the action of growth factors, inhibit angiogenesis.


Menstrual irregularities, premenstrual syndrome, algodismenorea, dysmenorrhea, fibrocystic mastopathy, retention ovarian cysts. as part of complex therapy for endometrial hyperplasia, uterine fibroids, endometriosis, polycystic ovary syndrome.


Dilute 30-40 drops of the drug in ½ cup boiled water at room temperature.

Take 30 minutes before meals 3 times a day. The course of treatment is at least 3 months, without interrupting intake during menstruation. The daily dose can be divided into 2 doses. If, after discontinuation of the drug, the symptoms reappear, therapy should be continued after consulting a doctor.


Hypersensitivity to the components of the drug.

Side effects

On the part of the skin, sometimes hypersensitivity reactions, allergic reactions, including skin rashes, hyperemia, itching, skin edema, infiltrated hyperemic spots can occur.

In case of any adverse reactions should stop using the drug and be sure to consult a doctor.

special instructions

Do not use during pregnancy and lactation.

Children. The drug should not be used in children, since the efficacy and safety of the drug in children have not been established.

The ability to influence the reaction rate when driving vehicles and working with other mechanisms. Does not affect.


If you need to use any other medicines, you should inform your doctor.


Cases of drug overdose are unlikely. however, disorders of the cardiovascular system may occur.

Treatment: gastric lavage, intake of activated carbon, symptomatic therapy.

Storage conditions

In the original packaging at a temperature not exceeding 25 ° C.

Tags: Tazalok